ADVERSE EFFECTS AFTER VACCINATION AGAINST SARS-COV-2 (COVID-19) IN DOWN SYNDROME ADULTS.
Introduction: Comorbidities in adults with Down syndrome are common making them a risk group for COVID-19. Thus, vaccinating against COVID-19 becomes necessary, but requires care against possible side effects. Objective: To investigate possible adverse effects after vaccination against COVID-19 in a...
| Publicado en: | ConScientiae Saúde Vol. 22; no. 1; pp. 1 - 10 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Nove de Julho University
2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176239348&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 176239348 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16771028 B0TO jtl: ConScientiae Saúde issn: 16771028 maglogo: N pubinfo: dt: 2023 vid: 22 iid: 1 pid: 59221 pub: Nove de Julho University artinfo: ui: 176239348 176239348 176239348 10.5585/22.2023.23794 176239348 ppf: 1 ppct: 9 formats: fmt: @attributes: type: P tig: atl: ADVERSE EFFECTS AFTER VACCINATION AGAINST SARS-COV-2 (COVID-19) IN DOWN SYNDROME ADULTS. aug: au: Lacerda de Andrade, Michele Uehara, Laura Ferreira de Moraes, Janaina Ferrari Corrêa, João Carlos Corrêa, Fernanda Ishida affil: Master, Doctoral and Master's Rehabilitation Science Programs, Nove de Julho University, São Paulo/SP, São Paulo, 01504-001, Brazil sug: subj: Adverse Health Care Event Immunization SARS-CoV-2 Down Syndrome In Adulthood Human Adult Descriptive Research Questionnaires Fever Muscle Pain Interviews Adult: 19-44 years ab: Introduction: Comorbidities in adults with Down syndrome are common making them a risk group for COVID-19. Thus, vaccinating against COVID-19 becomes necessary, but requires care against possible side effects. Objective: To investigate possible adverse effects after vaccination against COVID-19 in adults with Down Syndrome (DS). Methodology: Descriptive study in which ninety-seven adults diagnosed with DS were interviewed using a questionnaire containing seventeen questions related to personal and historical data, and seven questions related to vaccination. Results: The most applied vaccine was AstraZeneca (94%), Pfizer (4%), and CoronaVac (2%); 74% of the subjects had adverse effects, the most frequent after the first dose being pain at the injection site (65.3%), fever (37.9%), muscle pain (37.8%), malaise (29.5%); in the second dose there was a decrease in these adverse effects; 95% of symptoms disappeared after the first 24 hours following application. Conclusion: More than half of the individuals interviewed had adverse effects after the application of the first dose of the vaccine, decreasing with the second dose; the most frequent was pain at the site of application. Introdução: Comorbidades em adultos com síndrome de Down são comuns tornando-os um grupo de risco para COVID-19. Dessa forma, vacinar contra a COVID-19 torna-se necessária, mas requer cuidados contra possíveis efeitos colaterais. Objetivo: Pesquisar possíveis efeitos adversos após vacinação contra COVID- 19 em adultos com Síndrome de Down (SD). Metodologia: Estudo descritivo no qual 97 adultos diagnosticados com SD foram entrevistados por meio de um questionário contendo dezessete questões relacionadas a dados pessoais e histórico, e sete questões relacionadas à vacinação. Resultados: A vacina mais aplicada foi a AstraZeneca (94%), Pfizer (4%) e CoronaVac (2%); 74% dos sujeitos apresentaram efeitos adversos, sendo os mais frequentes após a primeira dose: dor no local da injeção (65,3%), febre (37,9%), dores musculares (37,8%), mal-estar (29,5%); na segunda dose houve diminuição desses efeitos adversos; 95% dos sintomas desapareceram após as primeiras 24 horas após a aplicação. Conclusão: Mais da metade dos indivíduos entrevistados apresentou efeitos adversos após a aplicação da primeira dose da vacina, diminuindo com a segunda dose; a mais frequente foi a dor no local de aplicação. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|